The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Influence of hormone therapy timing intake on disease free survival (DFS) for patients with high-risk early breast cancer: Results of the UCBG-UNIRAD phase III randomized trial.
 
Sylvie Giacchetti
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly
Research Funding - AstraZeneca (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Lilly; Merck
 
Enora Laas
No Relationships to Disclose
 
Thomas Bachelot
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Novartis; Pfizer; Roche; Seagen
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); SeaGen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; pfizer; Roche
 
Jerome Lemonnier
No Relationships to Disclose
 
Fabrice Andre
Stock and Other Ownership Interests - PEGASCY
Consulting or Advisory Role - Gilead Sciences (Inst); Guardant Health (Inst); MEDIMMUNE (Inst); Relay therapeutics (Inst)
Research Funding - AstraZeneca (Inst); Daiichi (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; GlaxoSmithKline; Novartis; Roche
 
David A. Cameron
Consulting or Advisory Role - Clarity Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Novartis (Inst); Oncolytics (Inst); Pfizer (Inst); Prima BioMed (Inst); Puma Biotechnology (Inst); Research Triangle Institute RTI Health Solutions (Inst); Roche (Inst); Roche (Inst); Samsung Bioepis (Inst); Sanofi (Inst); Seagen (Inst); Synthon (Inst); Zymeworks (Inst); Zymeworks (Inst)
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche (Inst)
 
Judith Bliss
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline/Novartis (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Sylvie Chabaud
No Relationships to Disclose
 
Anne-Claire Hardy-Bessard
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Eisai; GlaxoSmithKline; MSD; Novartis; Pfizer; Seagen
 
Magali Lacroix-Triki
Honoraria - Myriad Genetics
 
Jean-Luc Canon
No Relationships to Disclose
 
Marc Debled
No Relationships to Disclose
 
Mario Campone
Honoraria - Lilly; Novartis
Consulting or Advisory Role - Abbvie (Inst); AstraZeneca/MedImmune (Inst); Daiichi Sankyo Europe GmbH; Diaccurate (Inst); Lilly (Inst); Menarini; Novartis (Inst); PET-THERAPY (Inst); Pfizer; Pierre Fabre (Inst); Sandoz-Novartis (Inst); Sanofi (Inst); Seagen (Inst)
Speakers' Bureau - Amgen; Lilly (Inst); Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Pfizer
Other Relationship - Roche
 
Paul H. Cottu
Honoraria - Lilly O.; NanoString Technologies (Inst); Novartis (Inst); Pfizer; Roche
Consulting or Advisory Role - Lilly O.; Pfizer
Research Funding - Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche
 
Florence Dalenc
No Relationships to Disclose
 
Annabelle Ballesta
No Relationships to Disclose
 
Frederique Madeleine Penault-Llorca
Consulting or Advisory Role - Abbvie; Agendia; Amgen; Astellas Pharma; AstraZeneca; AstraZeneca (Inst); AstraZeneca/Daiichi Sankyo; BAYER; BMS; Clovis Oncology; Eisai Europe; Exact Sciences; Gilead Sciences; GlaxoSmithKline; Illumina; Janssen; Lilly; Lilly (Inst); MSD; MSD/AstraZeneca; NanoString Technologies; Novartis; Pfizer; Roche; Roche (Inst); SERVIER
Research Funding - Bayer (Inst); MSD (Inst); Myriad Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Bayer (Inst); MSD (Inst); Roche (Inst)
 
Fabien Reyal
Stock and Other Ownership Interests - Avatar Medical
Honoraria - Avatar Medical
 
Francis Lévi
No Relationships to Disclose
 
Anne-Sophie Hamy
No Relationships to Disclose